Radiation therapy for the solitary plasmacytoma

Détails

ID Serval
serval:BIB_0EEF3E165E2C
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
Radiation therapy for the solitary plasmacytoma
Périodique
Turkish Journal of Hematology
Auteur⸱e⸱s
Kocak Esenguel, Ballerini Giorgio, Zouhair Abderrahim, Ozsahin Mahmut
ISSN
1300-7777
Statut éditorial
Publié
Date de publication
2010
Volume
27
Numéro
2
Pages
57-61
Langue
anglais
Notes
Review
Résumé
Plasma-cell neoplasms are classically categorized into four groups as: multiple myeloma (MM), plasma-cell leukemias, solitary plasmacytomas (SP) of the bone (SPB), and extramedullary plasmacytomas (EMP). These tumors may be described as localized or diffuse in presentation. Localized plasma-cell neoplasms are rare, and include SP of the skeletal system, accounting for 2-5% of all plasma-cell neoplasms, and EMP of soft tissue, accounting for approximately 3% of all such neoplasms. SP is defined as a solitary mass of neoplastic plasma cells either in the bone marrow or in various soft tissue sites. There appears to be a continuum in which SP often progresses to MM. The main treatment modality for SP is radiation therapy (RT). However, there are no conclusive data in the literature on the optimal AT dose for SP. This review describes the interrelationship of plasma-cell neoplasms, and attempts to determine the minimal RT dose required to obtain local control.
Mots-clé
Solitary Plasmacytoma, Radiotherapy, Multiple Myeloma, Management, Rare-Cancer-Network, Extramedullary Plasmacytoma, Prognostic Features, Bone Plasmacytoma, Multiple-Myeloma, Neck Region, Soft-Tissue, Radiotherapy, Multicenter, Head
Web of science
Open Access
Oui
Création de la notice
06/07/2010 9:11
Dernière modification de la notice
20/08/2019 12:35
Données d'usage